Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jeffrey D. Fuller"'
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155451 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0151260.].
Externí odkaz:
https://doaj.org/article/a47d679a71cd4c0789328a727b13d979
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151260 (2016)
Invasive aspergillosis (IA) is a life-threatening systemic mycosis caused primarily by Aspergillus fumigatus. Early diagnosis of IA is based, in part, on an immunoassay for circulating fungal cell wall carbohydrate, galactomannan (GM). However, a wid
Externí odkaz:
https://doaj.org/article/de82ac630d244ec0901a01d8380a04d8
Autor:
Jeffrey D. Fuller, Samir N. Patel, Robert Needle, Frances B. Jamieson, A Rebbapragada, D Haldane, Paul N. Levett, Jean Longtin, L Hoang, Marc-Christian Domingo, Mulvey, RC Reyes, Jared Bullard, Roberto G. Melano, GJ German, M Gilmour, G Girouard, H Almohri
Publikováno v:
Relevé des maladies transmissibles au Canada. 42:103-110
Autor:
Linda Hoang, Jeffrey D. Fuller, Marc-Christian Domingo, RC Reyes, GJ German, Michael R. Mulvey, Robert Needle, Samir N. Patel, Jean Longtin, David Haldane, G Girouard, H Almohri, A Rebbapragada, Roberto G. Melano, M Gilmour, Frances B. Jamieson, Jared Bullard, Paul N. Levett
Publikováno v:
Canada Communicable Disease Report. 42:91-97
Autor:
Roberto G. Melano, Brigitte Lefebvre, Jeffrey D. Fuller, David Haldane, Paul Van Caeseele, Michael R. Mulvey, L Hoang, Laura F. Mataseje, Susan M. Poutanen, David A. Boyd
Publikováno v:
The Journal of antimicrobial chemotherapy. 73(3)
Objectives Since the first identification of the OXA-48 carbapenemase in 2001, Enterobacteriaceae harbouring OXA-48-like enzymes have been reported globally. Here, we applied WGS to characterize the molecular epidemiology of these bacterial isolates.
Autor:
Michael R. Mulvey, Laura F. Mataseje, Johannes A. Delport, Ross J. Davidson, Diane Roscoe, Jeffrey D. Fuller, Brigitte Lefebvre, L Hoang, Barbara M. Willey, David A. Boyd, Paul N. Levett
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Carbapenem-resistant Enterobacter cloacae complex isolates submitted to a reference laboratory from 2010 to 2015 were screened by PCR for seven common carbapenemase gene groups, namely, KPC, NDM, OXA-48, VIM, IMP, GES, and NMC-A/IMI. Nineteen of the
Autor:
T. M.S.C. Melhem, Arnaldo Lopes Colombo, Anna Maria Tortorano, Gloria M. González, Ana Espinel-Ingroff, J. P. Takahaschi, Jacques F. Meis, Sarah E. Kidd, Josep Guarro, John D. Turnidge, S. Cordoba, Jeffrey D. Fuller, P. Dufresne, Nathan P. Wiederhold, Maria Walderez Szeszs, Teresa Peláez, M. A. Pfaller, Mahmoud A. Ghannoum
Publikováno v:
Antimicrobial Agents and Chemotherapy, 60, 2, pp. 1079-84
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Antimicrobial Agents and Chemotherapy, 60, 1079-84
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Antimicrobial Agents and Chemotherapy, 60, 1079-84
The CLSI epidemiological cutoff values (ECVs) of antifungal agents are available for various Candida spp., Aspergillus spp., and the Mucorales. However, those categorical endpoints have not been established for Fusarium spp., mostly due to the diffic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54a7b5e8c357a2f59a84d2c07f0228a
https://europepmc.org/articles/PMC4750715/
https://europepmc.org/articles/PMC4750715/
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151260 (2016)
PLoS ONE
PLoS ONE
Invasive aspergillosis (IA) is a life-threatening systemic mycosis caused primarily by Aspergillus fumigatus. Early diagnosis of IA is based, in part, on an immunoassay for circulating fungal cell wall carbohydrate, galactomannan (GM). However, a wid
Publikováno v:
Medical Mycology. 44:659-664
Cerebral blastomycosis is a rarely reported disease. We report three cases of cerebral blastomycosis previously treated with standard antifungal therapy, which were subsequently successfully treated with voriconazole. The first is a 29-year-old man w
Autor:
Donald E. Low, Jeffrey D. Fuller
Publikováno v:
Clinical Infectious Diseases. 41:118-121
We reviewed all of the published reports of cases of fluoroquinolone treatment failures for respiratory tract infection due to fluoroquinolone-resistant Streptococcus pneumoniae. There were 20 ciprofloxacin and levofloxacin treatment failures reporte